RA Capital

Rounds

Reset filters

• A Alethio TherapeuticsLeadDevelops therapies for myeloproliferative neoplasms, a group of rare blood cancers. $90MSeries A · 5 Nov
• P Pinnacle MedicinesDevelops oral peptide drugs for immunology and cardiometabolic diseases $89MSeries B · 26 Mar
• A AdcytherixAntibody-drug conjugates for cancer built on novel payloads $122MSeries A · 16 Oct
• G GametoStem cell-derived therapies for fertility and menopause $44MSeries C · 12 Aug
• C Commons ClinicLeadSpecialist care network for musculoskeletal and multi-specialty preventive care $26MSeries B · 12 Jun
• S SpyGlass PharmaImplant releasing glaucoma drugs for years, placed during cataract surgery $75MSeries D · 2 Jun

No round matches these filters.

Often invests with

• aMoon1
• Andera Partners1
• Angelini Ventures1
• Bpifrance1
• Cancer Research Horizons1
• Courtside Ventures1
• Dawn Biopharma1
• Floating Point1